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The lecture will review experimental and clinical evidence for
an involvement of the endothelin system in promoting glomerular
dysfunction and damage. We will propose a network of pathophysio-
logical interactions involving paracrine effects of ET-1 in the distinct
glomerular cells. At last, the lecture will tease out speciﬁc pathophys-
iological contexts where clinical development are expected to bring
fruits and would meet therapeutic needs.
We will focus on experimental evidence for a regulatory role of
E T-1 in podocyte function and hypothesize non-exclusive patho-
physiological involvement of the ET-1 system in different glomerular
diseases with podocyte injury. First, ET-1 produced by injured glo-
merular or preglomerular endothelium could be freely ﬁltered through
the ﬁltration barrier and act on podocyte ETRs. This is expected to occur
in severe hypertension, hemolytic uremic syndrome (HUS) and throm-
botic microangiopathy (TMA), sickle cell disease, diabetic nephropathy
(DN), connective tissue diseases and vasculitis. We will brieﬂy review
evidences for increased ET-1 activity in the vasculature in IgA nephrop-
athy (IgAN) where vascular lesions are frequent and of prognostic
value. Second, ET-1 may be produced de novo by mesangial cells.
We will review the current evidence for ET-1 production by mesangial
cells, in particular in DN and IgAN. Third, scarce evidence suggest
that podocytes and glomerular parietal epithelial cells produce ET-1
that affects podocyte phenotype in a paracrine and autocrine fashion in
vitro. In this regard we will examine the current evidences in focal and
segmental glomerulosclerosis (FSGS) and crescentic glomerulonephri-
tis. This review and further studies may assist clinicians in optimally
designing clinical trials for patients at increased risk for CKD.
doi:10.1016/j.lfs.2013.12.202
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Circulating levels of the endothelium-derived peptide endothelin-1
(ET-1) are elevated in human obesity, and ET-1 mediated vascular
tone is increased. The renal artery is important in controlling intrarenal
blood ﬂow and is highly sensitive to ET-1. Whether or not ET-1 affects
renal artery tone in obesity is unknown. To investigate the role of
endogenous ET-1, a mouse model with tie-1 promoter-driven endo-
thelium-restricted heterozygous overexpression of preproendothelin-1
was used (TET+/−). Obesity was induced in TET+/− and WT
littermates by feeding a high fat diet for seven months; lean controls
were kept on standard chow. The main renal arteries were studied in
wire myographs testing contractions (in the presence of l-NAME) to
ET-1, serotonin (5-HT), and U46619, targeting ETA, 5-HT2, and TP
receptors, respectively. Contractions to ET-1 were comparable be-
tween groups (PD2 8.29 ± 0.05, n = 6–8); 5-HT-induced responses
were facilitated at lower concentrations in obese mice leading to a shift
in PD2 (lean 7.08 ± 0.02 vs. obese 7.23 ± 0.07, n = 5–8, P b 0.01).
Responses to U46619 were signiﬁcantly shifted to the left in renal
arteries of obese animals (PD2 8.57 ± 0.06 vs. lean 8.21 ± 0.05, n = 5–
8, P b 0.001), and the area under the curve was signiﬁcantly different
between lean and obese TET+/− mice (AUC 418 ± 23 vs. lean 319 ±
25, n = 5, P b 0.05). Thus, TET+/− had no effect on responses in lean
animals. By contrast, in obesity heterozygous overexpression of ppET-1
enhanced TXA2-mediated, but not 5-HT or ET-1 induced contractions of
the renal artery.
doi:10.1016/j.lfs.2013.12.203
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In proteinuric diseases, stimulation of proximal tubule cells (RPTECs)
by protein and endothelin-1 result in the activation of different
signal pathways, ultimately causing renal insufﬁciency. Therapeutic
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interventions are hampered by the lack of speciﬁc and easily detectable
markers. We described a regulatory pathway in which nuclear migra-
tion of protein kinase C α controls the release of pri-miRNA15a. After
endothelin-1 stimulation the migration of PKCα is inhibited, and
mature miRNA15a is made. Using qRT-PCR we detect miRNA15a in the
urine of adult and pediatric patients with membranous or minimal
change nephropathy. By laser-microdissection this miRNA is predom-
inantly located in the proximal tubules. In cell culture, human RPTECs
produce the highest miRNA15a levels after ET-1 stimulation. In rats
after 5/6 nephrectomy, miRNA15a is increased in the urine. By graded
sieving and qRT-PCR, the highest amount of miRNA15a is found in the
tubular fraction. Selegiline treatment upregulates PKCα in vitro and
in the murine adriamycin model, signiﬁcantly downregulating ET-1
induced miRNA15a production. Thus measuring urinary miRNA15a
levels: i) indicates the regulation of a signal pathway in RPTECs in vivo
in proteinuric conditions; ii) allows for the ﬁrst time to control the
effectiveness of a therapy aiming to protect proximal tubules.
doi:10.1016/j.lfs.2013.12.204
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Recently the endothelin (ET) system has emerged as a novel target
for the treatment of diabetic nephropathy (DN) with anti-proteinuric
actions. However, no evidence for a direct in vivo pathogenic effect of
ET-1 on podocytes has been shown. Despite podocyte dysfunction in
DN, speciﬁc ET-1 signaling in podocytes has not been investigated. This
study investigated ET signaling in podocytes during experimental DN.
We ﬁrst demonstrated that the prominent functional ET-1 receptors
eliciting rapid calcium transients in podocytes are ETBRs. Mice with a
podocyte-speciﬁc double deletion of ETAR and ETBR (Pod-ETRKO)were
rendered diabetic by streptozotocin injection. Whereas wild-type
diabetic mice developed mild DN with microalbuminuria, mesangial
matrix expansion and podocyte loss, Pod-ETRKO mice were protected
from diabetes induced glomerulosclerosis and podocyte loss. We next
found that total β-catenin and phospho- NFκB expressions are strongly
reduced in glomeruli from Pod-ETRKO mice. Moreover, ET-1 could
directly activate β-catenin and NFκB signaling pathways in freshly
isolated glomeruli. This is the ﬁrst evidence that ET-1 activation drives
development of glomerulosclerosis and podocyte loss through direct
activation of ETRs in podocytes, and likely, through NFκB and β-catenin
pathways. Surprisingly, both at the expression level and the functional
level, the ETBR subtype was found to be prominent. Furthermore, these
results indicate that activation of the ET-1 pathways selectively in
podocytes is involved in pathophysiological crosstalk that inﬂuences
mesangial architecture and sclerosis.
doi:10.1016/j.lfs.2013.12.205
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Urinary ET-1 (UET-1) excretion may result from cellular exposure
to shear stress but the relative contributions of renal blood ﬂow
and tubular ﬂow are not known. We measured changes in UET-1 in
response to changes in renal perfusion pressure (RPP) in the rat
in order to identify associations between UET-1, urinary ﬂow rate
(UV), urinary sodium excretion rate (UNaV) and RPP. Methods:
Seven male Sprague Dawley rats weighing 258 ± 17 g underwent
induced pressure natriuresis. Arterial blood pressure was measured
directly and urine was collected via tube cystotomy. RPP was initially
increased by ligation of both the coeliac and cranial mesenteric arteries
and subsequently of the distal aorta. Glomerular ﬁltration rate (GFR)
and effective renal plasma ﬂow (ERPF) were determined by FITC-
inulin and para- aminohippurate clearance, respectively. UET-1 was
measured by a sandwich ELISA assay (Biomedica). Urinary sodium
was measured by sodium-selective electrode analysis. Results: GFR
and ERPF did not change signiﬁcantly when RPP increased from
137 ± 9 to 162 ± 11 mmHg but signiﬁcant increases in UV (4 ± 1 to
97 ± 33 μl/min/g kw) and UNaV (1 ± 1 to 23 ± 9 μmol/min/g kw)
had linear relationships with RPP (r2 = 0.39, p = 0.022 and r2 =
0.51, p b0.001 respectively). UET-1 increased from 11 ± 7 to 42 ±
26 fg/min/g kw (p = 0.014) but was not predicted by RPP. UET-1
did, however, strongly correlate with UV (r = 0.69, p = 0.001) and
UNaV (r = 0.65, p = 0.002). Conclusions: In the rat, UET-1 is more
associated with renal tubular ﬂow than renal blood ﬂow at higher RPPs.
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